<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39450473</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2576-6422</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>18</Day></PubDate></JournalIssue><Title>ACS applied bio materials</Title><ISOAbbreviation>ACS Appl Bio Mater</ISOAbbreviation></Journal><ArticleTitle>Eco-Friendly and Low-Cost Synthesis of Transparent Antiviral- and Antibacterial-Coated Films Based on Cu<sub>2</sub>O and MIL-53(Al).</ArticleTitle><Pagination><StartPage>7280</StartPage><EndPage>7291</EndPage><MedlinePgn>7280-7291</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acsabm.4c00956</ELocationID><Abstract><AbstractText>This research presents the development of an innovative antimicrobial coating consisting of cuprous oxide (Cu<sub>2</sub>O) integrated with the metal-organic framework MIL-53(Al) through an eco-friendly and low-cost synthesis method that employs glucose as a reducing agent under mild conditions. The microstructural properties of the composite materials were characterized by using X-ray diffraction (XRD) and transmission electron microscopy (TEM). The antibacterial efficacy of the Cu<sub>2</sub>O-MIL-53(Al) (CuM) composite was assessed against <i>Escherichia coli</i> and <i>Staphylococcus aureus</i>, achieving a reduction efficacy of 99.99% with 5% copper incorporated into the MIL-53(Al) framework within a contact time of 24 h. The incorporation of CuM into a macromolecular host matrix of polyurethane-carboxymethylcellulose (CuM/PUD-CMC), applied as a coating on a low-cost plastic film, produced a transparent film with 87.10% transparency. This coating demonstrated a 99.99% reduction in <i>E. coli</i> and <i>S. aureus</i> populations within a contact time of 24 h. The CuM/PUD-CMC coating demonstrated substantial antiviral efficacy, achieving inactivation rates of 99.35% for Human Coronavirus 229E, 99.40% for Influenza A virus, and 97.76% for Enterovirus 71 within a contact time of 5 min. The CuM nanoparticles exhibited low toxicity toward zebrafish while effectively eradicating bacteria and inactivating viruses. The proposed low-cost material and coating method demonstrate significant potential as a broad-spectrum antimicrobial and antiviral agent, highlighting its suitability for various applications in biomedical and healthcare formulations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gamonchuang</LastName><ForeName>Jirasak</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Innovative Nanocoating Research Team, National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meeklinhom</LastName><ForeName>Sorrawit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Innovative Nanocoating Research Team, National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muangnapoh</LastName><ForeName>Tanyakorn</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Innovative Nanocoating Research Team, National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imhan</LastName><ForeName>Chalida</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Environmental Nanotechnology Research Team, National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chantho</LastName><ForeName>Varissara</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Nano Safety and Bioactivity Research Team, National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sillapaprayoon</LastName><ForeName>Siwapech</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nano Safety and Bioactivity Research Team, National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pimtong</LastName><ForeName>Wittaya</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Nano Safety and Bioactivity Research Team, National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warin</LastName><ForeName>Choochart</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nanocharacterization Research Team, National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isanapong</LastName><ForeName>Jantiya</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Applied Science, King Mongkut's University of Technology North Bangkok (KMUTNB), Bang Sue, Bangkok 10800, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratanatawanate</LastName><ForeName>Chalita</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Environmental Nanotechnology Research Team, National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumnorkaew</LastName><ForeName>Pisist</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2305-088X</Identifier><AffiliationInfo><Affiliation>Innovative Nanocoating Research Team, National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Appl Bio Mater</MedlineTA><NlmUniqueID>101729147</NlmUniqueID><ISSNLinking>2576-6422</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>789U1901C5</RegistryNumber><NameOfSubstance UI="D003300">Copper</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>T8BEA5064F</RegistryNumber><NameOfSubstance UI="C000520">cuprous oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073396">Metal-Organic Frameworks</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003300" MajorTopicYN="Y">Copper</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="Y">Escherichia coli</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013211" MajorTopicYN="Y">Staphylococcus aureus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="Y">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010316" MajorTopicYN="Y">Particle Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008422" MajorTopicYN="Y">Materials Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073396" MajorTopicYN="N">Metal-Organic Frameworks</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MIL-53(Al)</Keyword><Keyword MajorTopicYN="N">antibacterial activity</Keyword><Keyword MajorTopicYN="N">antiviral activity</Keyword><Keyword MajorTopicYN="N">composite polymer</Keyword><Keyword MajorTopicYN="N">cuprous oxide</Keyword><Keyword MajorTopicYN="N">metalâorganic framework</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39450473</ArticleId><ArticleId IdType="doi">10.1021/acsabm.4c00956</ArticleId></ArticleIdList></PubmedData></PubmedArticle>